로딩 중…
지수 로딩 중…
Ascendis Pharma A/S
ASND· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
DK
$230.83-0.14%
2026-06-18
Price Chart
Ascendis Pharma A/S+35.22%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $14.26B |
| Revenue | $984M |
| Net Income | $574M |
| Total Assets | $2.36B |
| Net Assets | $574M |
| Value | |
| P/E | 24.83x |
| P/B | 24.85x |
| P/S | 14.50x |
| FCF Yield | 0.33% |
| Profitability | |
| ROE | 100.10% |
| ROA | 24.38% |
| Op. Margin | -0.80% |
| Revenue Growth | 148.29% |
| Financial Health | |
| Debt Ratio | 310.53% |
| Total Debt | $1.05B |
| FCF | $48M |
| Cash | $674M |
| Current Ratio | 1.00x |
| Performance | |
| 1Y Return | 35.22% |
| 1M Return | -3.00% |
| From 52W High | -7.94% |
| 1Y MDD | -17.62% |
| Trading | |
| Volume | 886,084 shares |
| Trading Value | $206M |
| Per Share | |
| EPS | $-4.01 |